Apotea AB (publ)

Apotea AB (publ) FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Apotea AB (publ) (APOTEA.ST) as of Oct 30, 2026 is 51.46 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 19.73 % — a change of 160.84% (higher).

FCF Conversion

51.46 %

YoY

160.84%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Apotea AB (publ) is 2025 51.46 % . FCF Conversion Rate (FCF/EBITDA) of Apotea AB (publ) was 2024 19.73 % . It decreases by 160.84% higher compared to the previous year.

The Apotea AB (publ) FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2021
139.56 SEK
Jan 1, 2022
-555.78 SEK
Jan 1, 2023
108.85 SEK
Jan 1, 2024
19.73 SEK
Jan 1, 2025
51.46 SEK
The Apotea AB (publ) FCF Conversion history
YEARFCF ConversionYoY
51.46 %+160.84%
19.73 %-81.87%
108.85 %-119.59%
-555.78 %-498.23%
139.56 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Apotea AB (publ) Stock analysis

What does Apotea AB (publ) do? Apotea AB (publ) is a publicly listed company based in Stockholm, Sweden, operating within the Consumer Staples sector, specifically in the Retail industry. The company provides an online pharmacy service offering both non-prescription and prescription medications, alongside wholesale trade of cosmetics, general drugs, and other pharmacy-related products. Apotea AB (publ) has a workforce of 725 full-time employees. The company completed its initial public offering (IPO) on December 6, 2024, and is listed on the Stockholm Stock Exchange under the ticker symbol APOTEA.ST. Its official website is www.apotea.se. Apotea AB (publ) operates through a combination of online platforms and physical retail locations, delivering pharmacy services directly to consumers. The company's business model integrates digital commerce with traditional retail, focusing on accessibility and convenience for customers seeking pharmaceutical and cosmetic products. Apotea AB (publ) is headquartered in Stockholm, Sweden, and serves customers primarily within the Swedish market. The company's operations are centered around providing a comprehensive range of pharmacy-related products and services, emphasizing both online and offline retail channels. Apotea AB (publ) is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Apotea AB (publ) stock

FCF Conversion Rate (FCF/EBITDA) of Apotea AB (publ) is 51.46 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Apotea AB (publ) changed from 19.73 % to 51.46 %, representing a 160.84% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Apotea AB (publ) since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Apotea AB (publ) with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Apotea AB (publ)

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Apotea AB (publ)